VitaHealth Analysis
Expanded Cancer Panel – Female
VitaHealth Analysis Expanded Cancer Panel – Female
What’s it used for?
The test is used to provide information regarding indicators for three common cancers that affect women, including ovarian, colon, rectal, and breast cancer.
The presence of the carcinoembryonic antigen (CEA) in the blood may indicate certain kinds of cancers, typically colon and rectal, but sometimes pancreas, breast or lung. Cancer antigen (CA) 125 and CA 27-29 are tumor markers for ovarian cancer and breast cancer respectively.
VitaHealth Analysis
Expanded Cancer Panel - Female
| Carcinoembryonic Antigen (CEA) | CEA is associated with certain kinds of cancers, especially colon and rectal cancer. Elevated CEA levels are also found with other cancers including pancreatic, gastric, lung, ovary, and breast |
| Cancer Antigen (CA) 27.29 | The CA 27.29 is the premier blood test for breast cancer. In fact, the CA 27.29 is the only blood test specific for breast cancer |
| Cancer Antigen CA-125 | CA 125 is the premier test for the diagnosis and management of ovarian cancer |